TrialArthritis care & research2013

Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial.

Arthur Kavanaugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.